Paradigm Biopharmaceuticals (Paradigm Biopharmaceuticals) Days Sales Outstanding : 0.00 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Paradigm Biopharmaceuticals Days Sales Outstanding?

Paradigm Biopharmaceuticals's average Accounts Receivable for the six months ended in Dec. 2023 was $5.54 Mil. Paradigm Biopharmaceuticals's Revenue for the six months ended in Dec. 2023 was $0.00 Mil.

The historical rank and industry rank for Paradigm Biopharmaceuticals's Days Sales Outstanding or its related term are showing as below:

PBIGF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 90.09 Med: 139.79 Max: 37117.02
Current: 37117.02

During the past 8 years, Paradigm Biopharmaceuticals's highest Days Sales Outstanding was 37117.02. The lowest was 90.09. And the median was 139.79.

PBIGF's Days Sales Outstanding is ranked worse than
100% of 893 companies
in the Biotechnology industry
Industry Median: 73.34 vs PBIGF: 37117.02

Paradigm Biopharmaceuticals's Days Sales Outstanding declined from Dec. 2022 (5,840.00) to Dec. 2023 (0.00).

Paradigm Biopharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Paradigm Biopharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paradigm Biopharmaceuticals Days Sales Outstanding Chart

Paradigm Biopharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

365.00

94.51

148.28

Paradigm Biopharmaceuticals Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial												14,642.77	19,512.29	5,840.00	1,166.70	-

Competitive Comparison of Paradigm Biopharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Paradigm Biopharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paradigm Biopharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Paradigm Biopharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Paradigm Biopharmaceuticals's Days Sales Outstanding falls into.

Paradigm Biopharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Paradigm Biopharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (0.013	+	0)	/	1 )	/	0.032	*	365
=	0.013					/	0.032	*	365
=	148.28

Paradigm Biopharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	5.54)	/	1 )	/	0	*	365 / 2
=	5.54					/	0	*	365 / 2
=	N/A

Paradigm Biopharmaceuticals (OTCPK:PBIGF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Paradigm Biopharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Paradigm Biopharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Paradigm Biopharmaceuticals (Paradigm Biopharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Paradigm Biopharmaceuticals Ltd (OTCPK:PBIGF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

PAR:Australia

Address

500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000

Website

https://www.paradigmbiopharma.com

Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).